果納芬注射筆450國際單位/0.75毫升 Taivāna - ķīniešu - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

果納芬注射筆450國際單位/0.75毫升

台灣默克股份有限公司 台北市內湖區堤頂大道2段89號6樓 (23526610) - follitropin alfa(r-hfsh) - 注射劑 - follitropin alfa(r-hfsh) (6818000500) mcg - follitropin alfa - 女性患者(1)婦女經clomiphene citrate治療,仍無法排卵者(含多囊性卵巢症,pcod) 。(2)對於實施人工生殖協助技術(art),如體外受精(ivf),配子輸卵管植入(gift),合子輸卵管植入(zift)的病人,可刺激其多濾泡發育。(3)與黃體刺激素(lh)併用,使用於嚴重缺乏黃體刺激激素與濾泡刺激激素患者的濾泡刺激成長。男性患者治療男性對於患有先天或後天性腺刺激素不足之性腺功能低下症,併用人類絨毛膜性腺刺激素(hcg),刺激精子生成。

果納芬注射筆900國際單位/1.5毫升 Taivāna - ķīniešu - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

果納芬注射筆900國際單位/1.5毫升

台灣默克股份有限公司 台北市內湖區堤頂大道2段89號6樓 (23526610) - follitropin alfa(r-hfsh) - 注射劑 - follitropin alfa(r-hfsh) (6818000500) mcg - follitropin alfa - 女性患者(1)婦女經clomiphene citrate治療,仍無法排卵者(含多囊性卵巢症,pcod) 。(2)對於實施人工生殖協助技術(art),如體外受精(ivf),配子輸卵管植入(gift),合子輸卵管植入(zift)的病人,可刺激其多濾泡發育。(3)與黃體刺激素(lh)併用,使用於嚴重缺乏黃體刺激激素與濾泡刺激激素患者的濾泡刺激成長。男性患者治療男性對於患有先天或後天性腺刺激素不足之性腺功能低下症,併用人類絨毛膜性腺刺激素(hcg),刺激精子生成。

欣保富力靜脈營養輸注液 Taivāna - ķīniešu - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

欣保富力靜脈營養輸注液

台灣柏朗股份有限公司 台北市松山區健康路152號9樓 (23525106) - isoleucine;;leucine;;lysine hcl;;methionine;;threonine;;valine;;arginine;;histidine hcl monohydrate;;alanine;;glycine (eq to aminoacetic acid)(eq to glycocoll);;aspartic acid;;glutamic acid;;proline;;serine;;phenylalanine;;tryptophan;;glucose monohydrate;;sodium hydroxide;;sodium chloride;;sodium acetate trihydrate (eq to sodium acetate 3h2o );;sodium dihydrogen phosphate dihydrate;;potassium acetate;;magnesium acetate tetrahydrate;;calcium chloride dihydrate;;zinc acetate dihydrate;;triglycerides medium chain;;soybean oil ( eq to soya bean oil) - 注射劑 - potassium acetate (4008000100) mg; sodium acetate trihydrate (eq to sodium acetate 3h2o ) (4008000670) mg; calcium chloride dihydrate (4012000350) mg; magnesium acetate tetrahydrate (4012001450) mg; sodium chloride (4012002100) mg; glucose monohydrate (4020000760) (eq. to anhydrous glucose 64.0mg)mg; soybean oil ( eq to soya bean oil) (4020001600) mg; alanine (4020100200) mg; arginine (4020100300) mg; aspartic acid (4020100400) mg; glutamic acid (4020100700) mg; histidine hcl monohydrate (4020100915) (eq. to histidine 1.0 mg)mg; isoleucine (4020101000) mg; leucine (4020101200) mg; lysine hcl (4020101310) (eq. to lysine 1.81mg)mg; methionine (4020101500) mg; phenylalanine (4020101700) mg; proline (4020101800) mg; serine (4020101900) mg; threonine (4020102000) mg; tryptophan (4020102100) mg; valine (4020102300) mg; glycine (eq to aminoacetic acid)(eq to glycocoll) (4020102400) mg; sodium dihydrogen phosphate dihydrate (5612002611) mg; triglycerides medium chain (5640001102) mg; zinc acetate dihydrate (9200010550) ug; sodium hydroxide (9600028200) mg - combinations - 患者在無法使用或不適宜或不充足使用口服,腸道營養劑時,作為靜脈營養治療之熱量、必需脂肪酸、胺基酸、電解質及液體的補充。

鎝-99M孳生器 Taivāna - ķīniešu - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

鎝-99M孳生器

元新儀器有限公司 台北市大安區仁愛路四段33號9樓之3 (12669301) - aluminum oxide (alumina);;radioactive sodium molybdate (99mo)solution;;radioactive sodium molybdate (99mo)solution;;radioactive sodium molybdate (99mo)solution;;radioactive sodium molybdate (99mo)solution;;radioactive sodium molybdate (99mo)solution;;radioactive sodium molybdate (99mo)solution - 注射劑 - 主成分 (sodium pertechnetate (99mtc)injection generator 1unit:) ; aluminum oxide (alumina) (5604000700) gm; radioactive sodium molybdate (99mo)solution (9200008880) 不同包裝(濃度不同)gbq; radioactive sodium molybdate (99mo)solution (9200008880) 不同包裝(濃度不同)gbq; radioactive sodium molybdate (99mo)solution (9200008880) 不同包裝(濃度不同)gbq; radioactive sodium molybdate (99mo)solution (9200008880) 不同包裝(濃度不同)gbq; radioactive sodium molybdate (99mo)solution (9200008880) 不同包裝(濃度不同)gbq; radioactive sodium molybdate (99mo)solution (9200008880) 不同包裝(濃度不同)gbq - technetium (99mtc) compounds - 腦瘤及腦血管障礙之診斷